Irkutsk
Ulan-Ude

Blagoveshchensk
Chita
Yakutsk

Birobidzhan
Vladivostok
Khabarovsk

Magadan
Yuzhno-Sakhalinsk

Anadyr
Petropavlovsk-
Kamchatsky
Moscow

This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.

Sputnik V vaccine developers talked about the condition of the subjects

Sputnik V vaccine developers talked about the condition of the subjects
Photo: pixabay.com

The Sputnik V vaccine developers spoke about the condition of the first test subjects. There were no health complaints from the volunteers, however, in some, the PCR test for coronavirus showed a positive result.

As the RIA News" with reference to the head of the S. The gamaleys of Alexander Gintsburg, the participants in the first vaccine trials, are doing well, no one even caught a cold. He explains the positive result of the PCR test by the fact that some patients received a placebo, but who exactly will be known in mid-November.

According to Gunzburg, post-registration tests of the Sputnik V drug are ongoing, during which 40 thousand volunteers will receive the vaccine, a quarter of them will receive a placebo.

Half of the volunteers have already received the first component of the vaccine, and nine thousand have received the second vaccine. The scientist noted that no new adverse reactions appeared. 38 volunteers took part in the first testing of the Sputnik V vaccine.

Tests of the Russian vaccine against coronavirus "Sputnik V" last more than two years... The drug created by the N.I. Gamalei, will undergo post-registration tests until the end of 2022. Registration of the first vaccine against coronavirus took place in Russia on August 11.

November 27: current information on coronavirus in the Far East
Digest of regional events and latest statistics